Last reviewed · How we verify
NCT05223972
Effect of Lyon and Schroth Techniques on Adolescent İdiopathic Scoliosis
NA trial testing Schroth Treatment in Adolescent Idiopathic Scoliosis in 34 participants. Completed in 30 June 2022.
12 June 2022
Quick facts
| Lead sponsor | Kirsehir Ahi Evran Universitesi |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 10 March 2022 |
| Primary completion | 12 June 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Schroth Treatment
Conditions studied
- Adolescent Idiopathic Scoliosis — all drugs for Adolescent Idiopathic Scoliosis →
Sponsor
Kirsehir Ahi Evran Universitesi — full company profile →
Who can join
Adults 10 to 18, any sex, with Adolescent Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Today, it is known that the conservative treatment of scoliosis is gaining importance. In addition, no study has been found comparing the efficacy of two important conservative treatment methods, the Schroth and Lyon method, in adolescent idiopathic scoliosis. Accordingly, this study was conducted to compare the effectiveness of schroth and Lyon exercises in individuals with AIS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05223972
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adolescent Idiopathic Scoliosis
Currently open trials in the same condition.
- NCT07249515 — Scapula and Upper Extremity Performance in Scoliosis · recruiting
- NCT07430098 — Feedback-Based Balance Training for Adolescents With Idiopathic Scoliosis · NA · active not recruiting
- NCT06680297 — Preoperative Carbohydrate Drink in Adolescent Idiopathic Scoliosis Surgery: the Impact on Safety and Enhanced Recovery · NA · recruiting
- NCT06279468 — Clinical Effectiveness of Intervertebral Disc Release in Treating Lenke 5 Adolescent Idiopathic Scoliosis · NA · recruiting
- NCT06416579 — Comparison of the Efficiency of Schroth Method and Virtual Reality Exercises in Individuals With AIS · NA · recruiting
Other Kirsehir Ahi Evran Universitesi trials
Trials by the same sponsor.
- NCT07506915 — The Effect of Cognitive Behavioral Therapy · NA · enrolling by invitation
- NCT07502248 — PENG Block With or Without PPD Block for Postoperative Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
- NCT07438392 — Tecar Therapy in Chronic Knee Osteoarthritis · NA · not yet recruiting
- NCT07450742 — Digital Storytelling and Mother's Knowledge and Attitudes Towards Newborn Screning · NA · not yet recruiting
- NCT07414017 — Comparison of Focus of Attention in Virtual Reality-Based Exercise Training in Older Adults With Low Back Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05223972 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kirsehir Ahi Evran Universitesi
- Last refreshed: 9 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05223972.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing